ZSAN

Zosano Pharma Stock Price

1.21
0.2838 (30.64%)
Upgrade to Real-Time
Regular Market
1.21
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Zosano Pharma Corporation ZSAN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.2838 30.64% 1.21 11:08:11
Open Price Low Price High Price Close Price Prev Close
1.1314 1.06 1.26 0.9262
Bid Price Ask Price Spread News
1.21 1.22 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
45,887 27,796,125 $ 1.14 $ 31,791,643 6,941,297 0.3275 - 1.99
Last Trade Time Type Quantity Stock Price Currency
11:08:12 100 $ 1.21 USD

Zosano Pharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 123.50M 102.07M 99.23M $ - $ - -2.34 -0.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Zosano Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZSAN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.9621.260.83020.91622237,071,2060.24825.78%
1 Month0.6251.260.5230.80302099,885,8910.58593.6%
3 Months0.401.260.32750.66966036,093,1310.81202.5%
6 Months0.941.990.32750.96764376,143,4720.2728.72%
1 Year1.461.990.32750.91172114,342,575-0.25-17.12%
3 Years9.0025.700.32752.181,927,280-7.79-86.56%
5 Years40.0070.780.32759.041,465,094-38.79-96.98%

Zosano Pharma Description

Zosano Pharma Corp is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications. The company only operating segment being developing human pharmaceutical products. All the business activities of the firm is functioned through the market of the United States. Its product includes Qtrypta (M207) which is a formulation of zolmitriptan delivered utilizing an Adhesive Dermally-Applied Microarray technology.


Your Recent History
NASDAQ
ZSAN
Zosano Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.